New antibiotic shows promise against Drug-Resistant lung bug
NCT ID NCT07372781
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests a new antibiotic called contezolid against a hard-to-treat lung infection caused by Mycobacterium abscessus. Twenty-four adults will take either contezolid or an older drug, linezolid, for 14 days. Researchers will measure how quickly the drug kills the bacteria in sputum samples to see if contezolid works as well or better than the current treatment.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- contezolid (an antibiotic)
- What this could lead to
- If contezolid works better than linezolid, it could offer a new treatment option for hard-to-treat Mycobacterium abscessus lung infections.
- What could go wrong
- This is a small, early-phase trial with only 24 people. The drug may not prove effective or safe in larger studies. Side effects are possible, and the infection often requires long-term therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONOTHERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing chest hospital affiliated to Capital medical university, Beijing Tuberculosis & Thoracic Tumor Research Institute
Beijing, Beijing Municipality, 101149, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a two-drug combo better tame prostate trouble?
- New drug candidate takes on stubborn lung infection
- New hope against Drug-Resistant lung infection?
- New drug shows promise for NF1 skin tumors in early trial
- New drug combo takes on rare, Drug-Resistant lung bug
- Desperate times: phage cocktail takes on Drug-Resistant lung bug